Cited 24 times in
Henoch–Schönlein purpura nephritis with nephrotic‐range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김지홍 | - |
dc.contributor.author | 이재승 | - |
dc.contributor.author | 정현주 | - |
dc.date.accessioned | 2017-10-26T05:56:14Z | - |
dc.date.available | 2017-10-26T05:56:14Z | - |
dc.date.issued | 2005 | - |
dc.identifier.issn | 0300-9742 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/150503 | - |
dc.description.abstract | Objective: To clarify the therapeutic role of cyclosporin A (CyA) for patients with Henoch–Schönlein purpura nephritis (HSPN) showing nephrotic‐range proteinuria. Methods: The clinical and histological findings of eight children (7.7±3.8 years), who were treated with CyA and prednisolone, were evaluated retrospectively. All underwent a renal biopsy before therapy, and six of the eight patients received a follow‐up biopsy after therapy. Results: The histological grade of the International Study of Kidney Disease in Children (ISKDC) was improved in all six patients who received a follow‐up biopsy (pre‐therapy, four grade IIIa and two grade IIIb; post‐therapy, one grade I and five grade II) and it was statistically significant (p = 0.031). The activity index was significantly decreased after therapy (8.3±1.6 vs. 3.5±1.5, p = 0.031), and the chronicity index (0.5±0.5 vs. 0.7±1.0) and tubulointerstitial (TI) scores (1.5±1.3 vs. 0.8±1.6) did not change. There was a reduction in proteinuria from 3.2±2.3 to 0.1±0.1 g/m2/day (p = 0.008) and renal function remained normal in all patients after therapy. However, one patient showed CyA‐induced nephrotoxicity at a second biopsy. After an average follow‐up period of 3.8 years, six patients showed normal urine and renal function, and two showed minor urinary abnormalities. Conclusion: This study suggests that CyA therapy is effective in reducing proteinuria, which is a known risk factor for the development of renal insufficiency in HSPN and may regress the renal pathology in patients with nephrotic‐range proteinuria. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Informa Healthcare | - |
dc.relation.isPartOf | SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adolescent | - |
dc.subject.MESH | Biopsy | - |
dc.subject.MESH | Child | - |
dc.subject.MESH | Child, Preschool | - |
dc.subject.MESH | Cyclosporine/administration & dosage* | - |
dc.subject.MESH | Drug Therapy, Combination | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Glucocorticoids/administration & dosage* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Immunosuppressive Agents/administration & dosage* | - |
dc.subject.MESH | Kidney/pathology | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Nephritis/drug therapy | - |
dc.subject.MESH | Nephritis/etiology | - |
dc.subject.MESH | Nephritis/pathology | - |
dc.subject.MESH | Nephrosis/drug therapy* | - |
dc.subject.MESH | Nephrosis/etiology | - |
dc.subject.MESH | Nephrosis/pathology | - |
dc.subject.MESH | Prednisolone/administration & dosage* | - |
dc.subject.MESH | Proteinuria/drug therapy | - |
dc.subject.MESH | Proteinuria/etiology | - |
dc.subject.MESH | Proteinuria/pathology | - |
dc.subject.MESH | Purpura, Schoenlein-Henoch/complications | - |
dc.subject.MESH | Purpura, Schoenlein-Henoch/drug therapy* | - |
dc.subject.MESH | Purpura, Schoenlein-Henoch/pathology | - |
dc.subject.MESH | Remission Induction | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Severity of Illness Index | - |
dc.title | Henoch–Schönlein purpura nephritis with nephrotic‐range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment | - |
dc.type | Article | - |
dc.publisher.location | England | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pediatrics (소아청소년과학교실) | - |
dc.contributor.department | Dept. of Pediatrics (소아청소년과학교실) | - |
dc.contributor.department | Dept. of Pathology (병리학교실) | - |
dc.contributor.googleauthor | J. I. Shin | - |
dc.contributor.googleauthor | J. M. Park | - |
dc.contributor.googleauthor | Y. H. Shin | - |
dc.contributor.googleauthor | J. H. Kim | - |
dc.contributor.googleauthor | J. S. Lee | - |
dc.contributor.googleauthor | H. J. Jeong | - |
dc.identifier.doi | 10.1080/03009740510026544 | - |
dc.contributor.localId | A01003 | - |
dc.contributor.localId | A03076 | - |
dc.contributor.localId | A03771 | - |
dc.relation.journalcode | J02635 | - |
dc.identifier.eissn | 1502-7732 | - |
dc.identifier.pmid | 16234188 | - |
dc.identifier.url | http://informahealthcare.com/doi/abs/10.1080/03009740510026544 | - |
dc.subject.keyword | 16234188 | - |
dc.contributor.alternativeName | Kim, Ji Hong | - |
dc.contributor.alternativeName | Lee, Jae Seung | - |
dc.contributor.alternativeName | Jeong, Hyeon Joo | - |
dc.citation.volume | 34 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 392 | - |
dc.citation.endPage | 395 | - |
dc.identifier.bibliographicCitation | SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, Vol.34(5) : 392-395, 2005 | - |
dc.date.modified | 2017-05-04 | - |
dc.identifier.rimsid | 42783 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.